ATE108799T1 - Konjugate von in position c-3 eine detergens- kette enthaltenden vinca-derivaten. - Google Patents

Konjugate von in position c-3 eine detergens- kette enthaltenden vinca-derivaten.

Info

Publication number
ATE108799T1
ATE108799T1 AT89400334T AT89400334T ATE108799T1 AT E108799 T1 ATE108799 T1 AT E108799T1 AT 89400334 T AT89400334 T AT 89400334T AT 89400334 T AT89400334 T AT 89400334T AT E108799 T1 ATE108799 T1 AT E108799T1
Authority
AT
Austria
Prior art keywords
conjugates
derivatives containing
chain
detergent
vinca
Prior art date
Application number
AT89400334T
Other languages
English (en)
Inventor
Rao Ksp Siva Bhushana
Jean-Paul Dejonghe
Marie-Paule Collard
Andre Trouet
Original Assignee
Wallone Region
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wallone Region filed Critical Wallone Region
Application granted granted Critical
Publication of ATE108799T1 publication Critical patent/ATE108799T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
AT89400334T 1988-02-08 1989-02-07 Konjugate von in position c-3 eine detergens- kette enthaltenden vinca-derivaten. ATE108799T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8801439A FR2626882B1 (fr) 1988-02-08 1988-02-08 Conjugues de derives de vinca comportant une chaine detergente en position c-3

Publications (1)

Publication Number Publication Date
ATE108799T1 true ATE108799T1 (de) 1994-08-15

Family

ID=9363041

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89400334T ATE108799T1 (de) 1988-02-08 1989-02-07 Konjugate von in position c-3 eine detergens- kette enthaltenden vinca-derivaten.

Country Status (8)

Country Link
US (1) US5024835A (de)
EP (1) EP0328446B1 (de)
JP (1) JP2930965B2 (de)
AT (1) ATE108799T1 (de)
CA (1) CA1336119C (de)
DE (1) DE68916820T2 (de)
ES (1) ES2057157T3 (de)
FR (1) FR2626882B1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4122210C2 (de) * 1991-07-04 1999-04-01 Deutsches Krebsforsch Konjugate aus tumoraktiver Verbindung und Serumalbumin sowie Verfahren zu deren Herstellung und ihre Verwendung
US5379254A (en) * 1992-10-20 1995-01-03 National Semiconductor Corporation Asymmetrical alternate metal virtual ground EPROM array
US5599686A (en) * 1994-06-28 1997-02-04 Merck & Co., Inc. Peptides
US6143864A (en) * 1994-06-28 2000-11-07 Merck & Co., Inc. Peptides
US5866679A (en) * 1994-06-28 1999-02-02 Merck & Co., Inc. Peptides
WO1996005863A1 (fr) * 1994-08-19 1996-02-29 La Region Wallonne Composes, composition pharmaceutique et dispositif de diagnostic les comprenant et leur utilisation
DE4433890C2 (de) * 1994-09-22 1999-02-18 Deutsches Krebsforsch Konjugat aus einem Wirkstoff und einem nicht als körperfremd angesehenen, nativen Protein
EP0845987A4 (de) * 1995-08-08 2000-05-24 Fibrogen Inc C - proteinaseinhibitoren zur behandlung von störungen, die mit einer kollagenüberproduktion zusammenhängen
US5998362A (en) * 1996-09-12 1999-12-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US5948750A (en) * 1996-10-30 1999-09-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US6127333A (en) * 1997-07-10 2000-10-03 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US6391305B1 (en) 1997-09-10 2002-05-21 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
ZA9810974B (en) * 1997-12-02 1999-06-03 Merck & Co Inc Conjugates useful in the treatment of prostate cancer
ID24735A (id) * 1997-12-02 2000-08-03 Merck & Co Ltd Konjugat-konjugat yang berguna pada pengobatan kanker prostat
US20040081659A1 (en) * 1997-12-02 2004-04-29 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
WO2000006582A1 (en) * 1998-07-31 2000-02-10 Goldsmith Seeds, Inc. Trimeric and polymeric alkaloids
US6174858B1 (en) 1998-11-17 2001-01-16 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US7425541B2 (en) * 1998-12-11 2008-09-16 Medarex, Inc. Enzyme-cleavable prodrug compounds
AU2001266853B2 (en) * 2000-06-14 2005-02-17 Medarex, Inc. Prodrug compounds with an oligopeptide having an isoleucine residue
JP2004527727A (ja) * 2000-07-05 2004-09-09 シーアールティ ホールディングス、インク 電磁気放射起動プラズマ反応炉
US20030232760A1 (en) * 2001-09-21 2003-12-18 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US20090017023A1 (en) * 2002-08-14 2009-01-15 Macrogenics, Inc. FcGammaRIIB Specific Antibodies and Methods of Use Thereof
US8946387B2 (en) * 2002-08-14 2015-02-03 Macrogenics, Inc. FcγRIIB specific antibodies and methods of use thereof
US8187593B2 (en) * 2002-08-14 2012-05-29 Macrogenics, Inc. FcγRIIB specific antibodies and methods of use thereof
US8530627B2 (en) * 2002-08-14 2013-09-10 Macrogenics, Inc. FcγRIIB specific antibodies and methods of use thereof
US8193318B2 (en) * 2002-08-14 2012-06-05 Macrogenics, Inc. FcγRIIB specific antibodies and methods of use thereof
US8968730B2 (en) * 2002-08-14 2015-03-03 Macrogenics Inc. FcγRIIB specific antibodies and methods of use thereof
US8044180B2 (en) * 2002-08-14 2011-10-25 Macrogenics, Inc. FcγRIIB specific antibodies and methods of use thereof
US7960512B2 (en) 2003-01-09 2011-06-14 Macrogenics, Inc. Identification and engineering of antibodies with variant Fc regions and methods of using same
CA2512729C (en) 2003-01-09 2014-09-16 Macrogenics, Inc. Identification and engineering of antibodies with variant fc regions and methods of using same
US20050148534A1 (en) * 2003-09-22 2005-07-07 Castellino Angelo J. Small molecule compositions and methods for increasing drug efficiency using compositions thereof
CN1878568A (zh) * 2003-11-05 2006-12-13 盘林京有限公司 Cdim结合抗体的增强的b细胞细胞毒性
CA2565874C (en) 2004-05-10 2017-10-03 Macrogenics, Inc. Humanized fc.gamma.riib-specific antibodies and methods of use thereof
AU2005335714B2 (en) * 2004-11-10 2012-07-26 Macrogenics, Inc. Engineering Fc antibody regions to confer effector function
PL2573114T3 (pl) * 2005-08-10 2016-10-31 Identyfikacja i inżynieria przeciwciał z wariantami regionów FC oraz sposoby ich stosowania
EP1999470A4 (de) * 2006-03-10 2009-08-19 Macrogenics Inc Identifizierung und herstellung von antikörpern mit variierenden schweren ketten und anwendungsverfahren dafür
WO2008105886A2 (en) * 2006-05-26 2008-09-04 Macrogenics, Inc. HUMANIZED FCγRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
WO2008002933A2 (en) * 2006-06-26 2008-01-03 Macrogenics, Inc. Combination of fcgammariib antibodies and cd20-specific antibodies and methods of use thereof
ES2599319T3 (es) 2006-06-26 2017-02-01 Macrogenics, Inc. Anticuerpos específicos de Fc RIIB y métodos de uso de éstos
US20080112961A1 (en) * 2006-10-09 2008-05-15 Macrogenics, Inc. Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
US8652466B2 (en) * 2006-12-08 2014-02-18 Macrogenics, Inc. Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting
ES2589912T3 (es) 2008-04-02 2016-11-17 Macrogenics, Inc. Anticuerpos específicos para el complejo BCR y procedimientos de uso de los mismos
WO2009123894A2 (en) * 2008-04-02 2009-10-08 Macrogenics, Inc. Her2/neu-specific antibodies and methods of using same
US20110081347A1 (en) * 2008-06-04 2011-04-07 Macrogenics, Inc. Antibodies with Altered Binding to FcRn and Methods of Using Same
JP5898082B2 (ja) 2009-10-07 2016-04-06 マクロジェニクス，インコーポレーテッド フコシル化程度の変更により改良されたエフェクター機能を示すＦｃ領域含有ポリペプチドおよびその使用法
PH12012501751A1 (en) 2010-03-04 2012-11-12 Macrogenics Inc Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
EP2542256B1 (de) 2010-03-04 2019-05-22 MacroGenics, Inc. Mit b7-h3 reagierende antikörper, immunologisch wirkende fragmente davon und verwendungen davon
US9487587B2 (en) 2013-03-05 2016-11-08 Macrogenics, Inc. Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
AU2015358532C1 (en) * 2014-12-03 2020-10-29 Genentech, Inc. Quaternary amine compounds and antibody-drug conjugates thereof
GEP20227398B (en) 2016-04-15 2022-07-25 Macrogenics Inc Novel b7-h3 binding molecules, antibody drug conjugates thereof and usage thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU83822A1 (fr) * 1981-12-08 1983-09-01 Omnichem Sa Derives n-(vinblastinoyl-23)d'acides amines,leur preparation et leur application therapeutique
OA06421A (fr) * 1980-06-10 1981-09-30 Omnium Chimique Sa Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides.
FI820020L (fi) * 1981-01-12 1982-07-13 Lilly Industries Ltd Immunoglobulinkonjugater
GB2137210B (en) * 1983-03-30 1986-11-19 Lilly Industries Ltd Immunoglobulin conjugates
DE3484691D1 (de) * 1983-04-29 1991-07-18 Omnichem Sa Konjugierte vinblastin-verbindungen und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
EP0232693A3 (de) * 1985-12-16 1988-04-06 La Region Wallonne Konjugate des Vinblastins und seiner Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
FR2592883B1 (fr) * 1986-01-13 1988-09-16 Ire Celltarg Sa Derives de vinblastine et composition pharmaceutique les contenant
EP0233101A1 (de) * 1986-01-13 1987-08-19 Ire-Celltarg S.A. Vinblastin-Derivate und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
EP0328446A1 (de) 1989-08-16
CA1336119C (fr) 1995-06-27
JP2930965B2 (ja) 1999-08-09
US5024835A (en) 1991-06-18
FR2626882B1 (fr) 1991-11-08
JPH02152992A (ja) 1990-06-12
ES2057157T3 (es) 1994-10-16
DE68916820D1 (de) 1994-08-25
FR2626882A1 (fr) 1989-08-11
EP0328446B1 (de) 1994-07-20
DE68916820T2 (de) 1995-03-09

Similar Documents

Publication Publication Date Title
ATE108799T1 (de) Konjugate von in position c-3 eine detergens- kette enthaltenden vinca-derivaten.
IL89503A0 (en) Taxol derivatives,pharmaceutical compositions containing the same and process for the preparation thereof
GR3031180T3 (en) Pharmaceutical and other dosage forms.
MY106598A (en) Compositions and methods for drug delivery and chromatography.
IL83079A (en) Nitrilotriacetic acid derivatives,metal chelate resins prepared therefrom and their use in chromatography
ATE375363T1 (de) Derivate des wachstumshormons und verwandte proteine
HUT40561A (en) Pharmaceutical compositions containing active agents being instable or insoluble in water, and process for producing these compounds
GB8922026D0 (en) Novel anti-viral and cytotoxic agent
DE3751808D1 (en) N-substituierte thioakylphenothiazine
NO913887L (no) Inklusjonskomplekser med silybinin, fremstilling av disseog farmasoeytiske preparater inneholdende disse
ZA941198B (en) Highly concentrated TCF pharmaceutical preparations
JPS5533497A (en) Silaasubstituted 1*44dihydropyridine derivative
DK369287D0 (da) Immunotoksiner og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem
EP0367489A3 (de) Gerinnungsbeständige Materialien und Verfahren zu ihrer Herstellung
IL95863A0 (en) Anticoagulant peptides and compositions containing them
IT8919964A0 (it) Proteine inibenti i ribosomi e loro derivati.
GR3004303T3 (de)
FR2592883A1 (fr) Derives de vinblastine et composition pharmaceutique les contenant
ATE96331T1 (de) Fr115224 enthaltende zusammensetzung fuer eine parenterale verabreichung.
NZ228023A (en) 24(r)-scymnol; preparatory processes and pharmaceutical compositions
ES2171183T3 (es) Analogos y conjugados de piperidina con procainamida y napa.
DE59107762D1 (de) Komplexe, enthaltend S(+)-Phenyl-alkansäuren und alpha-Hydroxy-alkansäuren
EP0222722A3 (en) Conjugates of vinblastine and its derivatives, process for preparing them and pharmaceutical compositions containing these conjugates
ZA882762B (en) Novel derivative of d.25,process for its preparation,its use as an immunostimulant,and pharmaceutical compositions containing the derivative
IT1237783B (it) Derivati di ferro-albumina biodisponibile, loro procedimento di preparazione e relative composizioni farmaceutiche.